Repair of experimentally induced femoral chondral defect in a rabbit model using Lyophilized growth promoting factor extracted from horse blood platelets (L-GFequina).

The research study examines the effectiveness of a novel protein growth factor, Lyophilized equine platelet derived growth factors (LGF), in repairing articular cartilage injury in rabbits. The results suggest this method potentially improves healing and could be beneficial for regenerative medicine.

Experimental Design

• The study used 20 rabbits with artificially created full-thickness cartilage defects in both femoral condylar articular surfaces, essentially simulating an osteoarthritic condition.
• One joint of each rabbit was injected with an adjuvant (a substance that enhances the body’s immune response) as a control, while the other was treated with LGF.
• Four and eight weeks post-surgery, the femoral condyles (the rounded ends of the femur that come into contact with the tibia) were analyzed for signs of repair using gross, microscopic, and immunohistochemical assessment.

Measurement Parameters

• The levels of inflammatory and growth-promoting cytokines (TNF-α, IL-1β, PDGF and TGF-β1) within the cartilage defects were measured using the ELISA technique.
• The gene expression of collagen types I and II (Col I and Col II), which are important for cartilage formation, were also measured via RT-qPCR.

Findings and Conclusions

• The LGF treated defects showed significantly higher International Cartilage Repair Society (ICRS) healing scores, indicating improved cartilaginous regeneration.
• Similarly, histological examination using the O’Driscoll scoring system also revealed a higher score for the LGF treated group, suggesting enhanced tissue healing.
• LGF also resulted in lower levels of pro-inflammatory cytokines TNF-α and IL-1β, indicating a reduction in inflammation.
• Increased levels of PDGF and TGF-β1, two growth factors involved in tissue repair and blood vessel formation, were noted in the LGF treated joints.
• Furthermore, LGF significantly elevated the expression of the chondrogenic-related marker genes Col I and Col II, implicating an increase in cartilage formation.
• The study concluded that LGF improves chondral healing and could be a superior candidate as adjunctive therapy for the regeneration of cartilage defects in osteoarthritic patients.